Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice
Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice
复制标题
DOI:
10.1016/j.jconrel.2023.01.012
复制
发表时间:
2023-01-12
影响因子:
10.8
通讯作者:
Ishida, Tatsuhiro
中科院分区:
文献类型:
--
作者:
Ibrahim, Mohamed;Shimizu, Taro;Ishida, Tatsuhiro
Polyethylene glycol (PEG), a polyether compound, is available in molecular weights from -300 g/mol to -10,000,000 g/mol. In the molecular weight range of -750 to -5000, PEG is commonly used in bioconjugation technology and nano-formulations to improve the circulation half-life of the formulations and increase their stability. In cosmetics, lower molecular weight PEG compounds such as PEG 60 or PEG 100 are widely used as emulsifiers and skin penetration enhancers. PEG polymers are generally recognized as biologically inert and nonimmunogenic. However, it is recently reported that the "pre-existing" anti-PEG antibodies have been detected in high percentages of healthy individuals who have never received treatment with parenteral PEGylated formulations. To the best of our knowledge, we are the first to attempt to find an explanation for the source of preexisting anti-PEG antibodies in healthy individuals. In a murine study, we demonstrated that topically applied PEG derivatives, present in two commercially available cosmetic products, could efficiently penetrate the stratum corneum and reach the systemic circulation. The skin penetration of PEG derivatives was further enhanced in injured or otherwise compromised skin. Daily application of cosmetic PEG derivatives primed the immune system, inducing anti-PEG IgM production. Anti-PEG IgM was detected by Day 14 in mice with normal skin, while anti-PEG IgM was detected as early as day 7 in mice with compromised skin. In addition, in mice with preinduced circulating levels of anti-PEG IgM, topically applied PEG derivatives from cosmetic products appeared to bind to the pre-induced anti-PEG IgM, lowering blood levels. Current results indicate that PEG derivatives in cosmetic products may be an important contributor to the source of the "pre-existing" anti-PEG antibodies that have been detected in healthy individuals.